Introduction
Equid herpesvirus-1 (EHV-1) is an alpha herpesvirus which causes respiratory disease and leads to a cell associated viraemia which, via endothelial cell infection and thromboischaemia results in late gestation abortion or neonatal foal death . Despite routine vaccination of pregnant mares, sporadic EHV-1 abortion outbreaks can still occur.
Host risk factors for the development of herpes viral abortion, including the role of the mare's Major Histocompatibility Complex (MHC) class I genotype have received little attention to date. Classical equine MHC class I genes, also known as the Equine Leukocyte Antigen (ELA) complex, encode a large number of polymorphic alleles (Tallmadge et al., 2005) .
These allelic polymorphisms determine the range of peptides presented to cytotoxic T lymphocytes (CTL). Fifteen MHC class I serological ELA haplotypes have been identified at the ELA-A locus, but only a small number of haplotypes are common in the Thoroughbred breed, namely ELA-A2, ELA-A3, ELA-A5, ELA-A9 and ELA-A10 (Antczak, 1992) . The sharing of MHC class I alleles between individuals can also be demonstrated functionally in vitro using an EHV-1 specific, cytotoxic T lymphocyte assay (Allen et al., 1995) . One EHV-1 CTL target is the immediate early protein (ICP4, encoded by gene 64), which is restricted by the B2 allele expressed on the ELA-A3 haplotype and an unknown allele on ELA-A2 (Kydd et al., 2014) . Recently, the B2 allele (Eqca-1*00101 using the current nomenclature) has been shown to bind a single 9 residue peptide, namely RDGARFGEL within the immediate early protein (Bergmann et al., 2015) . The frequency of the B2 allele is relatively common with estimates ranging from 13.4% to 25% in Thoroughbred horses (Bergmann et al., 2015; Antczak, D.F 1986) .
The study described here exploited a field outbreak of multiple abortions in a herd of Thoroughbred mares to explore associations between several risk factors and pregnancy losses, some but not all of which were confirmed as EHV-1 positive. These preliminary results suggested a significant association between pregnancy loss and the mare's MHC class I allele, regardless of the EHV-1 status of the feto-placental unit. No other significant associations were identified and vaccination provided partial protection.
Materials and methods

Groups of horses
Three separate groups of horses were used, namely the Cornell (n=9), Newmarket (n=40) and commercial pregnant Thoroughbred (n=46) herds. The Cornell horses were used to produce template cDNA for RT-PCR based tests to identify five known ELA haplotypes in the Thoroughbred horse. This herd consisted of 10 horses of known MHC class I haplotypes, previously characterised by serological typing and test matings. Nine homozygous horses included three carrying ELA-A2, three with ELA-A3, one ELA-A5 and one ELA-A9 Thoroughbreds and one ELA-A10 Standardbred horse. The heterozygote carried the ELA-A2 and ELA-A5 haplotypes. These horses were used for the optimisation of the allele-specific RT-PCRs using a panel of primer pairs. The second group (unrelated to the first) comprised 40 Newmarket Thoroughbreds of unknown haplotype that included a mixed family of halfand full-siblings, with eight foals by the same sire and six dams. Samples from these animals were used to validate the RT-PCR in an uncharacterised population. All horses were maintained according to national and institutional care guidelines, all samples were excess to requirements when horses were sampled for other reasons and standard ethical approval procedures were completed. The third group comprised 46 pregnant Thoroughbred mares which were used for commercial breeding purposes in which an EHV-1 outbreak occurred (details below).
RT-PCRs for MHC class I genotyping
Using cDNA extracted from peripheral blood mononuclear cells, RT-PCRs were developed (Supplementary File 1) to detect selected, sequenced alleles specific for five known ELA haplotypes in the Thoroughbred horse. To design allele-specific primers, sequence data of all the equine MHC class I genes (classical and non-classical) previously identified from the haplotypes ELA-A2, -A3, -A5, -A9, and -A10 were obtained from GenBank ® and aligned using ClustalW2 (www.ebi.ac.uk/Tools/clustalw2/index.html). Five MHC class I alleles, one per haplotype, were selected based on differences in sequence in the hypervariable regions (8-9 (A2 haplotype), B2 (A3.1), 5b (A5), 9c (A9) and 10a (A10; Supplementary File 2).
These common haplotypes represent approximately 90% of animals in the Thoroughbred breed (D.F. Antczak, personal communication). The genes from which the alleles originated had previously been assigned to four MHC class I loci (Supplementary File 3; see (Tallmadge et al., 2010) for nomenclature). To capture any additional alleles, generic RT-PCR primers were also used (adapted from (Chung et al., 2003) ) that closely matched homologous regions of all the classical MHC class I genes but did not bind to known non-classical and pseudogene sequences. A sample of each RT-PCR amplicon was electrophoresed and visualized according to standard protocols. Following amplification, all RT-PCR products were cloned and sequenced using standard methods.
Commercial Thoroughbred broodmares, pregnancy losses and inclusion criteria
Pregnant Thoroughbred mares (n=46) were maintained on a well-managed stud farm in England and had been vaccinated against EHV-1 and EHV-4 as recommended with an inactivated, whole virus vaccine with carbomer adjuvant (Equip EHV-1,4, Zoetis UK Ltd., London). These mares shared a common paternal or maternal sire at the fourth or fifth generation. The herd also included five mares which were half-sisters out of two dams.
Following confirmation of two consecutive EHV-1 positive abortions, 46 mares were followed to determine their pregnancy outcome. Pregnancy losses which occurred at >100 days of gestation and <1 day post partum were included in the analysis. 
Detection of cytotoxic T lymphocyte (CTL) activity
To confirm and extend RT-PCR results, CTL assays were performed using lymphocytes from selected Thoroughbred mares to determine the presence of a shared MHC class I allele (Allen et al., 1995 CTL target when presented by products of the B2 allele (ELA-A3) and potentially, the ELA-A2 haplotype (Kydd et al., 2014; Kydd et al., 2006 
Results
Characterisation of the MHC class I allele-specific RT-PCR
For each pair of primers, RT-PCR products of the predicted size were obtained from lymphocyte cDNA originating from the Cornell horses (Supplementary File 4) . Each product was present only in the specific predicted haplotype and there was no evidence that the allelespecific primers amplified any products from other haplotypes. Each RT-PCR product was sequenced and this matched the published database sequences, thus confirming the amplification of the allele of interest.
The five allele-specific primer pairs were then used to test cDNA samples from 40
Newmarket Thoroughbreds of unknown MHC haplotypes. Each sample produced an RT-PCR product of the expected size from at least one set of the allele-specific primers. A total of 28 cDNA samples generated an RT-PCR product from 2 sets of gene-specific primer pairs indicating a heterozygous genotype. The remaining 12 cDNA samples generated a RT-PCR product from just one allele-specific primer pair. This latter result may be interpreted as: i)
that two copies of a single allele are present, demonstrating homozygosity or ii) that other alleles are present which are not recognised by any of the primer pairs, suggesting a heterozygous genotype. The 40 Newmarket Thoroughbreds included six mares which had eight offspring between them, sired by the same stallion (Table 1) . In three cases (offspring 1, 2 and 4), it is certain that the sire transmitted ELA-A3. In two cases (offspring 6 and 8) the sire transmitted either ELA-A5 or ELA-A9 and in one case (offspring 3) either ELA-A5 or an unknown haplotype. The data show that the sire carried ELA-A3 and suggests that the sire's other MHC haplotype was ELA-A5. This fits the segregation pattern for all eight offspring and supports the conclusion that offspring 3, 5, and 7 are true MHC homozygotes. Dams PM and TJ are possible homozygotes.
To confirm homozygosity in the 12 putative homozygous Newmarket Thoroughbred genes respectively (118 allele frequency 5%; 2/40).
Outbreak of pregnancy loss in Thoroughbred mares and associated risk factor analysis
Following two EHV-1 positive pregnancy losses, the outcome of pregnancy was monitored over one season in a total of 46 Thoroughbred mares and risk factors for pregnancy loss investigated. The management included keeping mares in small isolated groups at pasture, but all were stabled together in a large American barn, with shared airspace, for one night during particularly bad weather. Thirty six mares produced a viable foal but 10 pregnancy losses (22%) were recorded and 10 fetuses underwent post mortem diagnostic tests, although these were limited in one carcass (#29) due to predation of fetal tissues. Five of the 10 pregnancy losses were attributed to EHV-1 infection ( 
Cell mediated immune responses in Thoroughbred mares involved in the outbreak
MHC class I restricted, EHV-1 specific CTL activity was monitored once in PBMC from 5/10 mares with EHV-1 positive pregnancy loss ( (Kydd et al., 2014) , no definitive conclusion about mare 36's haplotype could be drawn so she was excluded in further analyses.
Application of the MHC class I allele specific RT-PCR to commercial Thoroughbred broodmares
The presence of alleles 8-9 (A2 haplotype), B2 (A3.1), 5b (A5), 9c (A9) and 10a (A10) was detected by RT-PCR in 29 mares (25 foaling and four pregnancy losses) and only by CTL assay in 1 mare (13). One or two RT-PCR products were detected in each of the mares, of which eight appeared homozygous and 21 heterozygous ( Table 2 ). The five half-sisters shared either allele 9b or 10c. A total of 30 genotyped mares were therefore included in the analysis. Of 25 mares that were genotyped and foaled normally, five mares (20%; mares 9, 32, 34, 35 and 39) had the B2 allele. Of these five mares, four were heterozygous (80%) and one was putatively homozygous. In contrast, in four of the 10 mares which lost their pregnancy and were RT-PCR typed, the B2 allele was detected in all four mares (100%; mares 5, 14, 29 and 38; Table 3 ). Of these four B2 + mares, two showed putatively homozygous (B2) and two heterozygous (B2/8-9 and B2/9c) genotypes.
To summarise the MHC class I alleles which were determined by RT-PCR and CTL assay in 30 mares, the percent allele frequency was calculated and the distribution according to pregnancy outcome illustrated (Figure 1 ). To reduce bias in putatively homozygous animals, the allele detected was counted once and "x" was assigned to the potential unknown allele.
The total of 16.7% B2 + (Eqca-1*00101) horses in the current study is comparable with the 13.4% reported by Bergmann et al., (2015) .
Statistical analysis of pregnancy outcome and MHC class I genotype
No statistically significant associations were found between pregnancy loss and mares' age, In contrast, a low prevalence of herpes simplex virus-1 infection and disease is associated with a high frequency of the Human Leukocyte Antigen (HLA-)-B*44 allele (Samandary et al., 2014) . In veterinary species, MHC class I genes have been associated with susceptibility to disease, including mastitis in cattle (Park et al., 2004) . In the horse, there is an association between MHC class I ELA-A9 haplotype and the development of uveitis (Deeg et al., 2004) .
The current data therefore add to the association between MHC class I and disease.
The association between a maternal B2 allele and all pregnancy losses, regardless of EHV-1 status was unexpected. Thus the B2 allele was also detected in two mares which suffered pregnancy loss and were diagnosed as EHV-1 negative using fetal and placental samples. A potential explanation is that regardless of the EHV-1 infection status, the B2 allele in the mare is associated with an inadequate or different innate or adaptive immune response, leading to the loss of a viable feto-placental unit. For example, antimicrobial peptides in the human reproductive tract show a high degree of genetic variation and immune-modulatory function (Yarbrough et al., 2015) , which may influence the innate immune response to pathogens and ultimately the outcome of pregnancy.
Intriguingly, the MHC class I B2 allele was detected in some mares which foaled successfully. Closer interrogation of the data showed that four out of five of these mares were heterozygous for the B2 allele. Thus it appears that heterozygosity of the mother may have an overriding positive influence on successful pregnancy outcome. Maternal heterozygosity may dampen any immuno-dominant effect normally associated with the B2 allele or, as discussed earlier, limit viral invasion and the subsequent immune response. Alternatively, it is possible that the allele inherited by the feto-placental unit from heterozygous mothers may have influenced pregnancy outcome, for example compromising the maternal tolerance to paternal antigens. The influence of individual alleles, such as B2 on this tolerance remains to be investigated. In women, the placental unit has the capacity to modulate local maternal immune responses (Racicot et al., 2014) . Thus inheritance of the B2 allele may alter the immunological equilibrium at the feto-maternal interface and / or make it more vulnerable to challenge by pathogens.
The significant association between pregnancy loss and the MHC class I B2 allele may be indicative of linkage with another unidentified locus or interaction with another risk factor. In women, genome wide association studies suggest that unexplained miscarriage may be associated with dysregulation of expressed genes involved in mitochondrial function and cytokine production (Lyu et al., 2013; Medica et al., 2009 ). In cattle, seven genes representing diverse pathways were moderately associated with fertility and early pregnancy loss (Minten et al., 2013) . Thus using the equine genome sequence (Wade et al., 2009 ) as a basis for future genome wide association screening of horses, any genes and biological pathways involved in pregnancy loss may be elucidated.
In conclusion, this study provides new but preliminary evidence of an apparent positive association between the loss of an equine pregnancy and the presence of the MHC class I B2 allele in the mother. This newly identified association requires confirmation in other populations with more complete data sets, but nevertheless highlights an avenue meriting further research. 
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Where only one RT-PCR product was amplified, the animal was likely to have been a homozygote, but 12 to reduce bias, was assigned an x allele (X haplotype). * Genotypes of mares 13 and 36 were 13 determined by CTL assay as B2 (A3 haplotype) and an unknown allele on the A2 haplotype or B2 14 respectively. Abbreviations: n/a= sample was not available for RT-PCR typing; no.= number; Mare no.
Pregnancy outcome MHC class I allele(s) detected
Predicted ELA-A haplotype a) First strand synthesis of RNA. All incubations were performed in a thermocycler with heated lid.
*Moloney Murine Leukaemia Virus Reverse Transcriptase
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Expand High Fidelity enzyme mix Step (1*00201; A9) and 10a (N*00501; A10). 
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ATGCGGATCG TGATGCCCCC AACCTTCCTC CTGCTGCTCT CGGGGGCCCT GAGCCTGACC GAGACCCTGG CTGGCTCCCA CTCCATGAGG TATTTCTACA
3.1(B2)
ATGTGCGTCA TGATGCCGCC AACCTTCCTC CTGCTGCTGT CGGGGGCCCT GACCCTGACC GAGACCTGGG CGGGCTCCCA CTCCATGAGA TATTACAAAA Supplementary File 6. Cytotoxic T lymphocyte activity in EHV-1 stimulated, Thoroughbred PBMC against the target cells shown. Effectors were stimulated with EHV-1 strain Ab4: a) EHV-1 hyperimmune pony mare expressing the MHC class I B2 allele was used as the positive assay control. b) to e) four Thoroughbred mares sampled once at 5-10 months after EHV-1 positive pregnancy loss.
3.1(B2) CCGCCGTGTC CCGGCCCGGC CGCGGGGAGC CCCGCTTCAT CTCCGTCGGC TACGTGGACG ACACGCAGTT CGTGCGGTTC GACAGCGACG CCGCGAGTCC
Target cells are shown on the x axis and are designated as either B2 allele positive or the number of the mare, followed by target cells' status: inf = infected with EHV-1; m = mock infected; g64 = NYVACC gene 64 infected Paillot et al., 2006) . Effector to target cell ratios 100:1, 50:1 and 25:1 as shown in a). Bars indicate standard error of mean of three replicate wells.
